Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8478665 | Molecular and Cellular Neuroscience | 2013 | 33 Pages |
Abstract
Parkinson's disease is the second most common neurodegenerative disease, and is characterised by the progressive degeneration of the nigrostriatal dopaminergic (DA) system. Current treatments are symptomatic, and do not protect against the DA neuronal loss. One of the most promising treatment approaches is the application of neurotrophic factors to rescue the remaining population of nigrostriatal DA neurons. Therefore, the identification of new neurotrophic factors for midbrain DA neurons, and the subsequent elucidation of the molecular bases of their effects, are important. Two related members of the bone morphogenetic protein (BMP) family, BMP2 and growth differentiation factor 5 (GDF5), have been shown to have neurotrophic effects on midbrain DA neurons both in vitro and in vivo. However, the molecular (signalling pathway(s)) and cellular (direct neuronal or indirect via glial cells) mechanisms of their effects remain to be elucidated. Using the SH-SH5Y human neuronal cell line, as a model of human midbrain DA neurons, we have shown that GDF5 and BMP2 induce neurite outgrowth via a direct mechanism. Furthermore, we demonstrate that these effects are dependent on BMP type I receptor activation of canonical Smad 1/5/8 signalling.
Keywords
GDF5Dorsomorphinnumber of repetitionsRT-PCRTGFPBSGDNFday(s) in vitroBMP2MAPKventral midbrainMitogen activated protein kinasesMTTtransforming growth factorThiazolyl blue tetrazolium bromideNeuronal differentiationdopaminergic/dopamineDIVSH-SY5Y cellsGlial cell line-derived neurotrophic factorPhosphate buffered salineReverse transcriptase-polymerase chain reactionBMP receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O'Keeffe,